Nektar Therapeutics (NASDAQ:NKTR) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:22 PM.
Here’s what investors need to know about the announcement.
Earnings
Nektar Therapeutics beat estimated earnings by 5.0%, reporting an EPS of $-0.19 versus an estimate of $-0.2.
Revenue was up $519 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 8.94% drop in the share price the next day.
Here’s a look at Nektar Therapeutics’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.25 | -0.45 | -0.45 |
| EPS Actual | -0.27 | -0.25 | -0.32 | -0.31 |
| Revenue Estimate | 21.83M | 19.84M | 22.13M | 22.61M |
| Revenue Actual | 20.50M | 21.59M | 22.02M | 23.62M |
To track all earnings releases for Nektar Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
